JP2019533691A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019533691A5 JP2019533691A5 JP2019522777A JP2019522777A JP2019533691A5 JP 2019533691 A5 JP2019533691 A5 JP 2019533691A5 JP 2019522777 A JP2019522777 A JP 2019522777A JP 2019522777 A JP2019522777 A JP 2019522777A JP 2019533691 A5 JP2019533691 A5 JP 2019533691A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- levels
- reduction
- hscrp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
- 239000000203 mixture Substances 0.000 claims 18
- 108010074051 C-Reactive Protein Proteins 0.000 claims 5
- 208000010125 myocardial infarction Diseases 0.000 claims 4
- 210000002377 thylakoid Anatomy 0.000 claims 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims 3
- 206010002383 Angina Pectoris Diseases 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 2
- 206010047249 Venous thrombosis Diseases 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- 208000028867 ischemia Diseases 0.000 claims 2
- 230000000243 photosynthetic effect Effects 0.000 claims 2
- 208000031229 Cardiomyopathies Diseases 0.000 claims 1
- 208000002330 Congenital Heart Defects Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000005764 Peripheral Arterial Disease Diseases 0.000 claims 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 claims 1
- 208000007474 aortic aneurysm Diseases 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 206010008118 cerebral infarction Diseases 0.000 claims 1
- 208000026106 cerebrovascular disease Diseases 0.000 claims 1
- 208000037976 chronic inflammation Diseases 0.000 claims 1
- 230000006020 chronic inflammation Effects 0.000 claims 1
- 208000028831 congenital heart disease Diseases 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 208000015210 hypertensive heart disease Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000002107 myocardial effect Effects 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000049 pigment Substances 0.000 claims 1
- 208000004124 rheumatic heart disease Diseases 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662417415P | 2016-11-04 | 2016-11-04 | |
| US62/417,415 | 2016-11-04 | ||
| PCT/CA2017/051306 WO2018081903A1 (en) | 2016-11-04 | 2017-11-03 | Composition for the prevention and/or treatment of cardiovascular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019533691A JP2019533691A (ja) | 2019-11-21 |
| JP2019533691A5 true JP2019533691A5 (https=) | 2020-12-17 |
Family
ID=62076517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019522777A Revoked JP2019533691A (ja) | 2016-11-04 | 2017-11-03 | 心血管疾患の予防及び／又は治療のための組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11033592B2 (https=) |
| EP (1) | EP3534924A4 (https=) |
| JP (1) | JP2019533691A (https=) |
| CA (1) | CA3039681A1 (https=) |
| WO (1) | WO2018081903A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230056443A1 (en) * | 2021-08-21 | 2023-02-23 | Nathalie Boucher | Equine gastric health formulation |
| CN115786246B (zh) * | 2022-12-16 | 2024-09-06 | 四川轻化工大学 | 斑马鱼免疫无应答性心力衰竭模型的构建方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2293852A1 (fr) * | 1999-12-30 | 2001-06-30 | Purecell Technologies Inc. | Procede de preparation d'extraits de plantes actifs et utiles a la capture de radicaux libres; les extraits, et compositions et dispositifs les comprenant |
| EP1401463B1 (en) | 2001-07-02 | 2005-09-21 | Purecell Technologies Inc. | Compositions comprising thylakoids useful in the modulation of the inflammation process |
| WO2005027944A1 (en) | 2003-09-22 | 2005-03-31 | Purecell Technologies Inc. | Oral compositions and route of administration for the delivery of a thylakoid extract |
| EP2320919B1 (en) * | 2008-07-14 | 2016-03-30 | Thylabisco Ab | Large-scale process for the preparation of thylakoids |
-
2017
- 2017-11-03 WO PCT/CA2017/051306 patent/WO2018081903A1/en not_active Ceased
- 2017-11-03 JP JP2019522777A patent/JP2019533691A/ja not_active Revoked
- 2017-11-03 US US16/347,613 patent/US11033592B2/en active Active
- 2017-11-03 CA CA3039681A patent/CA3039681A1/en active Pending
- 2017-11-03 EP EP17867471.9A patent/EP3534924A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Galiuto et al. | Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment | |
| RU2015149009A (ru) | 19-нор нейроактивные стероиды и способы их применения | |
| HRP20171950T1 (hr) | Pirimidinoni kao inhibitori faktora xia | |
| Lassnig et al. | Pheochromocytoma crisis presenting with shock and tako-tsubo-like cardiomyopathy | |
| JP2016517394A5 (https=) | ||
| FI3562487T3 (fi) | Metalloentsyymi-inhibiittoriyhdisteitä | |
| JP2019206562A5 (https=) | ||
| JP2019533691A5 (https=) | ||
| Pereira et al. | Myocardial stunning in hyperthyroidism | |
| Nair et al. | Heart transplant for anomalous origin of left coronary artery from pulmonary artery | |
| Manickam et al. | Design and synthesis of sulfonamidophenylethylureas as novel cardiac myosin activator | |
| Bonadei et al. | Ivabradine during cardiogenic shock: A clinical case and review of the literature | |
| Gojo et al. | Cardiac resurrection after bone-marrow-derived mononuclear cell transplantation during left ventricular assist device support | |
| Marin-Garcia et al. | Congenital absence of the pulmonary valve associated with tricuspid atresia and intact ventricular septum | |
| RU2017114993A (ru) | Твердая фармацевтическая композиция, содержащая амлодипин и лозартан | |
| Bishnoi et al. | Damus-Kaye-Stansel: Valuable option for retraining of left ventricle in late arterial switch for transposition of the great arteries | |
| CN116602970A (zh) | Bufalin在制备抗IHNV和IPNV的产品中的应用 | |
| CN101991573A (zh) | 去氢钩藤碱及其异构体在制备药物中的用途 | |
| Robin et al. | Consequences of total tricuspid valvulectomy without prosthetic replacement in treatment of Pseudomonas endocarditis | |
| Dahl et al. | Staphylococcus aureus endocarditis with fast development of aortic root abscess despite relevant antibiotics | |
| JP2016199470A (ja) | ヒトキマーゼ活性阻害剤および高血圧症の予防治療剤 | |
| US20130164847A1 (en) | Use of a protein tyrosine kinase inhibitor for inducing the differentiation of mesenchymal stem cells into cardiogenic cells | |
| Maxwell | Miriam Hospital morbidity and mortality conference, a case of transient heart failure | |
| Bayat et al. | Anomalous Origin of the Circumflex Branch from the Right Coronary Artery. | |
| Teja et al. | Bifid cardiac apex |